(Q42790613)

English

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

scientific article published on November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

0 references

ceftaroline fosamil

1 reference

ChEBI release 2020-05-28

1

object named as

Mark H Wilcox

0 references

author name string

G Ralph Corey

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

George H Talbot

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Dirk Thye

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

David Friedland

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Tanya Baculik

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

CANVAS 2 investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

65 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

iv53-iv65

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Waves of resistance: Staphylococcus aureus in the antibiotic era.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Staphylococcal surgical site infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Are methicillin-resistant Staphylococcus aureus that produce Panton-Valentine leucocidin (PVL) found among residents of care homes?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Systematic review of antimicrobial drug prescribing in hospitals.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ255

21 January 2018

Identifiers

10.1093/JAC/DKQ255

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42790613&oldid=1970544544"